ATE504300T1 - Harnstoffderivate als il-8-rezeptorantagonisten - Google Patents
Harnstoffderivate als il-8-rezeptorantagonistenInfo
- Publication number
- ATE504300T1 ATE504300T1 AT03781400T AT03781400T ATE504300T1 AT E504300 T1 ATE504300 T1 AT E504300T1 AT 03781400 T AT03781400 T AT 03781400T AT 03781400 T AT03781400 T AT 03781400T AT E504300 T1 ATE504300 T1 AT E504300T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor antagonists
- urea derivatives
- urea
- derivatives
- antagonists
- Prior art date
Links
- 108090001007 Interleukin-8 Proteins 0.000 title 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical class NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42195602P | 2002-10-29 | 2002-10-29 | |
PCT/US2003/033964 WO2004039775A2 (en) | 2002-10-29 | 2003-10-28 | Il-8 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE504300T1 true ATE504300T1 (de) | 2011-04-15 |
Family
ID=32230293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03781400T ATE504300T1 (de) | 2002-10-29 | 2003-10-28 | Harnstoffderivate als il-8-rezeptorantagonisten |
Country Status (16)
Country | Link |
---|---|
US (2) | US20060040952A1 (de) |
EP (2) | EP1558259B1 (de) |
JP (1) | JP4843220B2 (de) |
AR (1) | AR041834A1 (de) |
AT (1) | ATE504300T1 (de) |
AU (1) | AU2003287219A1 (de) |
CY (1) | CY1112135T1 (de) |
DE (1) | DE60336672D1 (de) |
DK (1) | DK1558259T3 (de) |
ES (1) | ES2362357T3 (de) |
MY (1) | MY143477A (de) |
PE (1) | PE20040607A1 (de) |
PT (1) | PT1558259E (de) |
SI (1) | SI1558259T1 (de) |
TW (1) | TW200418812A (de) |
WO (1) | WO2004039775A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009039091A1 (en) * | 2007-09-21 | 2009-03-26 | Smithkline Beecham Corporation | Method of treatment |
WO2006043950A1 (en) * | 2004-10-20 | 2006-04-27 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
MX2008013599A (es) * | 2006-04-21 | 2008-10-31 | Smithkline Beechman Corp | Antagonistas del receptor il-8. |
PL2009992T3 (pl) * | 2006-04-21 | 2012-11-30 | Glaxosmithkline Llc | Antagoniści receptora IL-8 |
TW200817006A (en) * | 2006-06-23 | 2008-04-16 | Smithkline Beecham Corp | IL-8 receptor antagonist |
US20170224679A1 (en) * | 2014-07-31 | 2017-08-10 | Glaxosmithkline Intellectual Property Development Limited | Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) |
CN111727184B (zh) * | 2018-01-11 | 2022-06-28 | 深圳嘉科生物科技有限公司 | Cxcr2拮抗剂 |
CN114286819B (zh) * | 2019-07-11 | 2024-03-05 | 深圳嘉科生物科技有限公司 | 一种cxcr2拮抗剂的晶型及其应用 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1792156A (en) | 1928-01-17 | 1931-02-10 | Gen Aniline Works Inc | 5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them |
US2363074A (en) | 1938-06-16 | 1944-11-21 | Geigy Ag J R | Halogen substituted acylamino sulphonic acids of the aromatic series and their manufacture |
US2407309A (en) | 1942-02-04 | 1946-09-10 | Squibb & Sons Inc | Chemotherapeutic agents of the sulphonamide type |
US2795610A (en) | 1955-03-31 | 1957-06-11 | Du Pont | Hydroxy-phenyl alkyl ureas |
BE639588A (de) | 1962-11-06 | |||
US3996253A (en) | 1966-01-11 | 1976-12-07 | Minnesota Mining And Manufacturing Company | Process for the preparation of color images |
GB1210596A (en) | 1967-04-06 | 1970-10-28 | Armour Grocery Products Compan | Antiseptic compositions |
CH506240A (de) | 1969-02-04 | 1971-04-30 | Ciba Geigy Ag | Verwendung von N-Hydroxyphenyl-N'-phenylharnstoffen zur Bekämpfung schädlicher Mikroorganismen ausserhalb der Textilindustrie |
SE370866B (de) | 1968-03-21 | 1974-11-04 | Ciba Geigy Ag | |
US3647819A (en) | 1969-09-19 | 1972-03-07 | Sterling Drug Inc | Indazolylphenylureas and indazolyl-phenylthioureas |
FR2100943A1 (en) | 1970-07-23 | 1972-03-24 | Ici Ltd | O-carboylcarbanilides from anthranilic acid and substd - isocyanates - immuno-suppressive agents |
US4048333A (en) | 1971-08-23 | 1977-09-13 | Medizinska Akademia | Method for treating a picorna virus infection |
DE2303761A1 (de) | 1973-01-26 | 1974-08-01 | Henkel & Cie Gmbh | Neue n,n'-disubstituierte thioharnstoffe, deren herstellung sowie verwendung als antimikrobielle substanzen |
US4008326A (en) | 1973-12-26 | 1977-02-15 | The Upjohn Company | Substituted ureas and thioureas and pharmaceutical compositions thereof |
US3932434A (en) | 1974-08-30 | 1976-01-13 | Eli Lilly And Company | N-2-(6-hydroxybenzothiazolyl)-N'-phenyl (or substituted phenyl) ureas |
JPS5598152A (en) | 1979-01-16 | 1980-07-25 | Hokko Chem Ind Co Ltd | Phenylurea derivative |
DE2928485A1 (de) | 1979-07-14 | 1981-01-29 | Bayer Ag | Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen |
GB2079480B (en) | 1980-07-08 | 1984-05-16 | Kodak Ltd | Heat-activated photographic and thermal recording processes employing precursor compounds |
US4608205A (en) | 1983-03-09 | 1986-08-26 | American Cyanamid Company | Polyanionic benzene ureas |
US4591604A (en) | 1984-03-28 | 1986-05-27 | American Cyanamid Company | Method of inhibiting the complement system by administering multisulfonated naphthalene ureas |
EP0344425B1 (de) | 1988-03-30 | 1993-12-08 | Warner-Lambert Company | N-[[(2,6-disubstituierte)phenyl]N'- arylalkyl] Harnstoffe als antihypercholesterolemische und antiatherosclerotische Mittel |
US5215570A (en) | 1988-10-20 | 1993-06-01 | Ciba-Geigy Corporation | Sulfamoylphenylureas |
US5290814A (en) | 1988-11-21 | 1994-03-01 | Burroughs Wellcome Co. | Anti-atherosclerotic diaryl compounds |
US5206234A (en) | 1990-10-22 | 1993-04-27 | Merck & Co., Inc. | Benzolactam analogs as antagonists of cck |
JPH05294935A (ja) | 1991-03-15 | 1993-11-09 | Green Cross Corp:The | アミノピリジン系化合物 |
AU659861B2 (en) | 1991-09-10 | 1995-06-01 | Sansho Seiyaku Co., Ltd. | Preparation for promoting hair growth |
JP2558427B2 (ja) * | 1992-06-08 | 1996-11-27 | ゼネラル・エレクトリック・カンパニイ | ポリカーボネート上にシリコーンを堆積する方法 |
NZ250916A (en) | 1993-02-27 | 1995-08-28 | Nihon Nohyaku Co Ltd | N-heteroaryl-n'-phenylureas, their use as acat inhibitors |
DK41193D0 (da) | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
US5312831A (en) | 1993-05-12 | 1994-05-17 | American Cyanamid Company | Urethanes and ureas that induce cytokine production |
CA2123728A1 (en) | 1993-05-21 | 1994-11-22 | Noriyoshi Sueda | Urea derivatives and their use as acat inhibitors |
US5547966A (en) | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
US5401758A (en) | 1993-10-07 | 1995-03-28 | Bristol-Myers Squibb Company | Pyridinyl cyanoguanidine compounds |
US5441984A (en) | 1994-01-06 | 1995-08-15 | Eli Lilly And Company | Urea, thiourea and guanidine derivatives |
US5576335A (en) | 1994-02-01 | 1996-11-19 | Nisshin Flour Milling Co., Ltd. | Urea derivatives and their use as ACAT inhibitors |
DE4413265A1 (de) | 1994-04-16 | 1995-10-19 | Basf Ag | Hydroxyphenylharnstoffe |
US5780483A (en) | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
EP0809492A4 (de) | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | Il-8 rezeptor antagonisten |
US6005008A (en) | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6211373B1 (en) * | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6133319A (en) | 1996-06-27 | 2000-10-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
EP0915651A4 (de) | 1996-06-27 | 2001-10-24 | Smithkline Beecham Corp | Il-8 rezeptor-antagonisten |
JP2000515495A (ja) | 1996-06-27 | 2000-11-21 | スミスクライン・ビーチャム・コーポレイション | Il―8レセプターアンタゴニスト |
EP0932405A4 (de) | 1996-06-27 | 2001-10-17 | Smithkline Beckman Corp | Il-8 rezeptor-antagonisten |
JP2000513359A (ja) | 1996-06-27 | 2000-10-10 | スミスクライン・ビーチャム・コーポレイション | Il―8受容体拮抗薬 |
JP2000515554A (ja) | 1996-08-06 | 2000-11-21 | スミスクライン・ビーチャム・コーポレイション | Il―8受容体アンタゴニスト |
EP0957907A4 (de) | 1996-08-06 | 2001-08-16 | Smithkline Beecham Corp | Il-8-rezeptor-antagonisten |
EP0948330A4 (de) | 1996-08-06 | 1999-12-01 | Smithkline Beecham Corp | Wendelantenne mit gebogenen segmenten |
JP2001527519A (ja) | 1996-08-15 | 2001-12-25 | スミスクライン・ビーチャム・コーポレイション | Il―8レセプターアンタゴニスト |
WO1998006398A1 (en) | 1996-08-15 | 1998-02-19 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
WO1998006399A1 (en) | 1996-08-15 | 1998-02-19 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
AR008290A1 (es) | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios. |
JP2001501172A (ja) | 1996-08-15 | 2001-01-30 | スミスクライン・ビーチャム・コーポレイション | Il―8レセプターアンタゴニスト |
WO1998007418A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
HUP0001943A3 (en) | 1997-01-23 | 2002-12-28 | Smithkline Beecham Corp | Benzimidazole and benzotriazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them |
US5929250A (en) | 1997-01-23 | 1999-07-27 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6436927B1 (en) | 1997-02-12 | 2002-08-20 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
AU8673198A (en) | 1997-07-29 | 1999-02-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
AR015425A1 (es) | 1997-09-05 | 2001-05-02 | Smithkline Beecham Corp | Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion |
AR015426A1 (es) | 1997-09-05 | 2001-05-02 | Smithkline Beecham Corp | Compuestos de benzotiazol antagonistas del receptor de il-8, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento,procedimiento para su preparacion, compuestos intermediarios y procedimiento para su preparacion |
WO1999036069A1 (en) | 1998-01-16 | 1999-07-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
CA2319063A1 (en) | 1998-01-20 | 1999-07-22 | Katherine L. Widdowson | Il-8 receptor antagonists |
WO2000006557A1 (en) | 1998-07-27 | 2000-02-10 | Smithkline Beecham Corporation | Novel process for making il-8 receptor antagonists |
JP2003525856A (ja) | 1998-08-28 | 2003-09-02 | スミスクライン・ビーチャム・コーポレイション | 2−アミノ−5−シアノフェノールの製法 |
JP2002523487A (ja) | 1998-08-28 | 2002-07-30 | スミスクライン・ビーチャム・コーポレイション | 3−ヒドロキシ−4−アミノ−ベンゾニトリルの改良された合成方法 |
DE69908156T2 (de) | 1998-09-23 | 2003-12-24 | Tularik Inc | Arylsulfonanilid-harnstoffe |
UY25842A1 (es) | 1998-12-16 | 2001-04-30 | Smithkline Beecham Corp | Antagonistas de receptores de il-8 |
AR029637A1 (es) | 1999-05-28 | 2003-07-10 | Smithkline Beecham Corp | Compuestos de guanidina, antagonistas de los receptores de la il-8, una composicion farmaceutica que los contiene y el uso de los mismos para la manufactura de un medicamento |
US20030225125A1 (en) | 1999-06-16 | 2003-12-04 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6372933B1 (en) | 1999-08-26 | 2002-04-16 | Smithkline Beecham Corporation | Process for preparing certain phenyl urea compounds |
US6440993B1 (en) | 1999-10-12 | 2002-08-27 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
JP2003524655A (ja) | 2000-03-01 | 2003-08-19 | スミスクライン・ビーチャム・コーポレイション | Il−8受容体アンタゴニスト |
US20030050298A1 (en) | 2000-03-10 | 2003-03-13 | Palovich Michael R | Il-8 receptor antagonists |
AR030273A1 (es) | 2000-03-10 | 2003-08-20 | Smithkline Beecham Corp | Compuestos de hidroxifenil urea sustituidos con sulfonamidas, composiciones farmaceuticas que los comprenden, y uso de los mismos en la fabricacion de medicamentos para tratar una enfermedad mediada por una quimioquina |
US6767922B2 (en) | 2000-03-14 | 2004-07-27 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6664259B2 (en) | 2000-03-16 | 2003-12-16 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
UY26627A1 (es) | 2000-03-24 | 2001-09-28 | Smithkline Beecham Corp | Antagonistas de receptores de il-8 |
EP1274428A4 (de) | 2000-04-07 | 2003-05-02 | Smithkline Beecham Corp | Il-8-rezeptorantagonisten |
US6432960B2 (en) | 2000-05-10 | 2002-08-13 | Bristol-Myers Squibb Company | Squarate derivatives of dihydropyridine NPY antagonists |
IL152775A0 (en) | 2000-05-30 | 2003-06-24 | Smithkline Beecham Corp | Il-8 receptor antagonists |
DE60216229T2 (de) | 2001-01-16 | 2007-10-04 | Smithkline Beecham Corp. | Il-8-rezeptorantagonisten |
EP1357909B1 (de) | 2001-01-16 | 2009-01-07 | Smithkline Beecham Corporation | Il-8-rezeptor-antagonisten |
JP2004529911A (ja) | 2001-02-02 | 2004-09-30 | シェーリング コーポレイション | Cxcケモカインレセプターアンタゴニストとしての3,4−二置換シクロブテン−1,2−ジオン |
US20030204085A1 (en) | 2001-02-02 | 2003-10-30 | Taveras Arthur G. | 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists |
JP2005507366A (ja) | 2001-03-30 | 2005-03-17 | スミスクライン・ビーチャム・コーポレイション | フェノール含有化合物の合成方法 |
CA2446193C (en) | 2001-06-05 | 2011-11-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
US20040038854A1 (en) | 2001-07-16 | 2004-02-26 | Dillon Susan B. | Use of il-8 receptor antagonists in the treatment of virus infections |
US20030028042A1 (en) | 2002-08-30 | 2003-02-06 | Palovich Michael R. | Il8-receptor antagonists |
US20030032802A1 (en) | 2002-08-30 | 2003-02-13 | Palovich Michael R. | IL8-receptor antagonists |
US20030065170A1 (en) | 2002-09-05 | 2003-04-03 | Widdowson Katherine Louisa | Il-8 receptor antagonists |
EP1631559A4 (de) | 2003-06-06 | 2008-08-27 | Smithkline Beecham Corp | Il-8-rezeptorantagonisten |
WO2006043950A1 (en) * | 2004-10-20 | 2006-04-27 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
PL2009992T3 (pl) | 2006-04-21 | 2012-11-30 | Glaxosmithkline Llc | Antagoniści receptora IL-8 |
TW200817006A (en) | 2006-06-23 | 2008-04-16 | Smithkline Beecham Corp | IL-8 receptor antagonist |
-
2003
- 2003-10-27 TW TW092129697A patent/TW200418812A/zh unknown
- 2003-10-27 MY MYPI20034079A patent/MY143477A/en unknown
- 2003-10-27 AR ARP030103917A patent/AR041834A1/es not_active Application Discontinuation
- 2003-10-28 AU AU2003287219A patent/AU2003287219A1/en not_active Abandoned
- 2003-10-28 EP EP03781400A patent/EP1558259B1/de not_active Expired - Lifetime
- 2003-10-28 WO PCT/US2003/033964 patent/WO2004039775A2/en active Application Filing
- 2003-10-28 PE PE2003001089A patent/PE20040607A1/es not_active Application Discontinuation
- 2003-10-28 JP JP2004548492A patent/JP4843220B2/ja not_active Expired - Lifetime
- 2003-10-28 EP EP11157820A patent/EP2388006A1/de not_active Withdrawn
- 2003-10-28 US US10/532,956 patent/US20060040952A1/en not_active Abandoned
- 2003-10-28 DE DE60336672T patent/DE60336672D1/de not_active Expired - Lifetime
- 2003-10-28 PT PT03781400T patent/PT1558259E/pt unknown
- 2003-10-28 ES ES03781400T patent/ES2362357T3/es not_active Expired - Lifetime
- 2003-10-28 AT AT03781400T patent/ATE504300T1/de active
- 2003-10-28 DK DK03781400.1T patent/DK1558259T3/da active
- 2003-10-28 SI SI200331999T patent/SI1558259T1/sl unknown
-
2007
- 2007-10-09 US US11/869,055 patent/US7709485B2/en not_active Expired - Lifetime
-
2011
- 2011-06-29 CY CY20111100624T patent/CY1112135T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004039775A2 (en) | 2004-05-13 |
US7709485B2 (en) | 2010-05-04 |
AU2003287219A8 (en) | 2004-05-25 |
PT1558259E (pt) | 2011-06-17 |
ES2362357T3 (es) | 2011-07-04 |
EP1558259B1 (de) | 2011-04-06 |
SI1558259T1 (sl) | 2011-06-30 |
PE20040607A1 (es) | 2004-09-18 |
MY143477A (en) | 2011-05-31 |
EP2388006A1 (de) | 2011-11-23 |
WO2004039775A3 (en) | 2004-08-26 |
JP2006506404A (ja) | 2006-02-23 |
US20060040952A1 (en) | 2006-02-23 |
CY1112135T1 (el) | 2015-11-04 |
AU2003287219A1 (en) | 2004-05-25 |
AR041834A1 (es) | 2005-06-01 |
EP1558259A2 (de) | 2005-08-03 |
TW200418812A (en) | 2004-10-01 |
US20090093492A1 (en) | 2009-04-09 |
DK1558259T3 (da) | 2011-07-11 |
DE60336672D1 (de) | 2011-05-19 |
EP1558259A4 (de) | 2009-04-08 |
JP4843220B2 (ja) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE384053T1 (de) | Triazolderivate als tachykininrezeptor- antagonisten | |
ATE413400T1 (de) | Cgrp-rezeptorantagonisten | |
NO20051871D0 (no) | Opioid reseptorantagonister | |
ATE344798T1 (de) | Als histamin-h3-antagonisten geeignete indolderivate | |
DE60331751D1 (de) | N-substituierte 2-oxodihydropyridinderivate als npy antagonisten | |
ATE346043T1 (de) | Il-8-rezeptorantagonisten | |
ATE518834T1 (de) | 2,3,4,9-tetrahydro-1h-carbazol-derivative als crth2-rezeptorantagonisten | |
DE60316411D1 (de) | Thiazolderivate als npy-rezeptorantagonisten | |
NO20016053L (no) | IL-8 reseptor-antagonister | |
DE60112051D1 (de) | Il-8 rezeptor antagonisten | |
ATE377008T1 (de) | Imidazolderivate als glutamatrezeptorantagonisten | |
DE60126480D1 (de) | Il-8 rezeptor-antagonisten | |
NO20016052D0 (no) | IL-8-reseptor-antagonister | |
ATE504300T1 (de) | Harnstoffderivate als il-8-rezeptorantagonisten | |
MA25739A1 (fr) | Antagonistes recepteurs il-8 | |
DK1180028T3 (da) | IL-8-receptorantagonister | |
ATE495168T1 (de) | Heteroarylsubstituierte imidazolderivate als glutamatrezeptorantagonisten | |
NO20015774L (no) | IL-8 reseptorantagonister | |
MA25659A1 (fr) | Antagonistes recepteurs il-8 | |
NO20016065D0 (no) | IL-8-reseptor-antagonister | |
NO20016102D0 (no) | IL-8 reseptorantagonister | |
DE602004018527D1 (de) | Furanderivate als ep4-rezeptorantagonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1558259 Country of ref document: EP |